Munafa Stock Market Course + Intraday & FNO calls 
Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Sonoma Pharmaceuticals (SNOA)
Technical Analysis Report for USA stock SNOA Sonoma Pharmaceuticals. Dated: 26 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals then click here. or read Experts views on Sonoma Pharmaceuticals or Forecast & share price targets of Sonoma Pharmaceuticals
Sonoma Pharmaceuticals Opened at 1.12 and Closed at: 1.12, which is 0.89% of previous session's close. It moved within a range of 1.10 and 1.20
The session was a Neutral session with an average volume of 62800, which is 26.11% of previous session's volumes.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 1.07 and resistance for tomorrow is 1.17
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.08, 1.04 resistance for tomorrow's hourly charts is 1.18, 1.24
10 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.14 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.19 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Sonoma Pharmaceuticals (SNOA) is 1.26 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.22 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Sonoma Pharmaceuticals is 1.73 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Sonoma Pharmaceuticals is at 1.19 and 200 DMA is at 1.73, while 50 DMA and 100 DMA are at 1.26 and 1.22 respectively
Sonoma Pharmaceuticals (SNOA) moving average of 20 SMA is at 1.19 and 20 EMA is at 1.17
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Mon Oct | 1.12 | 1.19 | 1.17 |
| 23 Fri Oct | 1.11 | 1.19 | 1.18 |
| 22 Thu Oct | 1.15 | 1.2 | 1.19 |
| 21 Wed Oct | 1.14 | 1.21 | 1.19 |
| 20 Tue Oct | 1.15 | 1.21 | 1.2 |
| 19 Mon Oct | 1.12 | 1.22 | 1.21 |
Sonoma Pharmaceuticals (SNOA) moving average of 50 SMA is at 1.26 and 50 EMA is at 1.23
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Mon Oct | 1.12 | 1.26 | 1.23 |
| 23 Fri Oct | 1.11 | 1.26 | 1.23 |
| 22 Thu Oct | 1.15 | 1.26 | 1.24 |
| 21 Wed Oct | 1.14 | 1.27 | 1.24 |
| 20 Tue Oct | 1.15 | 1.27 | 1.24 |
| 19 Mon Oct | 1.12 | 1.28 | 1.24 |
Sonoma Pharmaceuticals (SNOA) moving average of 100 SMA is at 1.22 and 100 EMA is at 1.37
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Mon Oct | 1.12 | 1.22 | 1.37 |
| 23 Fri Oct | 1.11 | 1.22 | 1.38 |
| 22 Thu Oct | 1.15 | 1.22 | 1.39 |
| 21 Wed Oct | 1.14 | 1.22 | 1.39 |
| 20 Tue Oct | 1.15 | 1.23 | 1.4 |
| 19 Mon Oct | 1.12 | 1.23 | 1.41 |
Sonoma Pharmaceuticals (SNOA) moving average of 200 SMA is at 1.73 and 200 EMA is at 1.62
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Mon Oct | 1.12 | 1.73 | 1.62 |
| 23 Fri Oct | 1.11 | 1.74 | 1.63 |
| 22 Thu Oct | 1.15 | 1.76 | 1.64 |
| 21 Wed Oct | 1.14 | 1.77 | 1.64 |
| 20 Tue Oct | 1.15 | 1.78 | 1.65 |
| 19 Mon Oct | 1.12 | 1.8 | 1.66 |
Teleflex Incorporated has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 18.8% more returns!
Resmed Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Resmed Inc, about 24.03% more returns!
Prestige Consumer has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Prestige Consumer, about 13.42% more returns!
Medtronic Plc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Medtronic Plc, about 19.24% more returns!
Mckesson Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Mckesson Corporation, about 25.21% more returns!
Edwards Lifesciences has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 13.22% more returns!
Centene Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Centene Corporation, about 19.76% more returns!
Becton Dickinson has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Becton Dickinson, about 18.32% more returns!
Zymeworks Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Zymeworks Inc, about 14.7% more returns!
Xencor Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Xencor Inc, about 27.24% more returns!
Veracyte Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Veracyte Inc, about 15% more returns!
United Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in United Therapeutics, about 33.52% more returns!
Sarepta Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 6.86% more returns!
Insulet Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Insulet Corporation, about 22.76% more returns!
Neogen Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Neogen Corporation, about 6.32% more returns!
Incyte Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Incyte Corporation, about 2.37% more returns!
Caredx Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 18.34% more returns!
Sonoma Pharmaceuticals has performed better than Argenx Se in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Agios Pharmaceuticals has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 21.06% more returns!
Sonoma Pharmaceuticals Technical analysis of indicators
Price action analysis of Sonoma Pharmaceuticals (SNOA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Sonoma Pharmaceuticals in short term and the sell signal is strong.
Sonoma Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Sonoma Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.14 and Sonoma Pharmaceuticals SNOA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sonoma Pharmaceuticals SNOA stock. Volume based technical analysis of Sonoma Pharmaceuticals SNOA stock is negative.
Sonoma Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SNOA Experts View which covers a lot of information including buying and selling signals
SNOA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sonoma Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
